Santosh Lamichhane
Academy Research fellow, Adj Prof (Docent), Group Leader,Infection and Immunity Unit at the Institute of Biomedicine.
santosh.lamichhane@utu.fi Link to Research Group ORCID-tunniste: https://orcid.org/0000-0002-9292-3595 |
Lipidomics/Metabolomics-
Gut microbial metabolism-
Multivariate data analysis
Reverse Metabolomics- Molecular networking
Lamichhane Group- Gut Microbiomics-The focus of our group is to explore microbial derived small molecules in the gut and their influence on human health.
Santosh Lamichhane is the Principal Investigator in the Infection and Immunity Unit at the Institute of Biomedicine. He is a Research Council of Finland Academy Research Fellow and holds the title of Docent (equivalent to Associate Professor) in Metabolomics at the Department of Life Technologies, University of Turku. As part of his research fellowship, Dr. Lamichhane investigates the relationship between gut microbiota, lipids, and their clinical effects in early childhood.
Lamichhane was a Visiting Researcher at The Dorrestein Lab, University of California, San Diego, where he gained expertise in reverse and repository-scale metabolomics to better understand microbial chemistry and its influence on human metabolism.
Lamichhane's research interest lies in the interface of human health, diet and gut microbial activity. He heads a research group (Gut Microbiomics) at Intitute of Biomedicine, Faculty of Medicine. https://sites.utu.fi/gutmicrobiomics/
The focus of his group is to explore microbial derived small molecules in the gut and their influence on human health. By integrating advanced laboratory techniques such as metabolomics, gut organoids, and microbial cultures with computational analysis, we investigate the chemical interactions between gut microbes and their impact on the host.
Metabolomics lecture in Systems biology (SYS21012), Modern biotechnologies and bioinformatics course (BIOT1524), Bioanalytical Techniques (CHEMI6429) at University of Turku.
- IL-22 resolves MASLD via enterocyte STAT3 restoration of diet-perturbed intestinal homeostasis (2024)
- Cell Metabolism
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Infant gut microbiota and negative and fear reactivity (2024)
- Development and Psychopathology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Multiplatform metabolomic interlaboratory study of a whole human stool candidate reference material from omnivore and vegan donors (2024)
- Metabolomics
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Serum proteomics of mother-infant dyads carrying HLA-conferred type 1 diabetes risk (2024)
- iScience
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Changes in lipids and inflammation in adults with super-refractory status epilepticus on a ketogenic diet (2023)
- Frontiers in Molecular Biosciences
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Circulating metabolic signatures of rapid and slow progression to type 1 diabetes in islet autoantibody-positive children (2023)
- Frontiers in Endocrinology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Classification of Common Food Lipid Sources Regarding Healthiness Using Advanced Lipidomics: A Four-Arm Crossover Study (2023)
- International Journal of Molecular Sciences
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Deep learning facilitates multi-data type analysis and predictive biomarker discovery in cancer precision medicine (2023)
- Computational and Structural Biotechnology Journal
(A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä) - Dynamics of the Lipidome in a Colon Simulator (2023)
- Metabolites
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Impact of exposure to per- and polyfluoroalkyl substances on fecal microbiota composition in mother-infant dyads (2023)
- Environment International
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )



